Form 4: Astera Labs CFO Gifts 7,000 Shares in Pre-Planned Move

Astera Labs' Chief Financial Officer, Michael Truett Tate, reported a gift of 7,000 shares of common stock, effective September 11, 2025.

Summary

• Michael Truett Tate, Chief Financial Officer of Astera Labs, Inc. (ALAB), reported a disposition of 7,000 shares of common stock.
• The transaction, dated September 11, 2025, was a bona fide gift of shares to a non-affiliated person.
• The gift was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction.
• Following this transaction, Mr. Tate directly holds 450,281 shares of Astera Labs common stock.
• An additional 203,727 shares are indirectly owned by the Tate 1997 Living Trust, for which Mr. Tate disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral. This Form 4 reports a routine, pre-planned insider gift of shares, which is a personal financial planning event and does not provide new information about the company's operational or financial health.

Future Outlook

No forward-looking statements or guidance regarding the company's performance or strategy were provided in this insider transaction report.

Industry Context

Insider gifts, particularly when pre-planned under Rule 10b5-1, are routine personal financial planning events for executives. This transaction does not inherently reflect on broader industry trends or the competitive landscape for Astera Labs.

Related Party Transactions

• The gift of 7,000 shares was made to a non-affiliated person.
• Indirect beneficial ownership of 203,727 shares is held by the Tate 1997 Living Trust, for which the reporting person disclaims beneficial ownership except for pecuniary interest.

Stakeholder Impact

• Shareholders: Minimal impact, as the gift of 7,000 shares represents a very small fraction of the company's total outstanding shares and the CFO's overall holdings. It does not signal a change in management's confidence in the company.

Key Dates

Recommendation

This Form 4 details a routine, pre-planned gift of a relatively small number of shares by the CFO. It does not offer any new insights into Astera Labs' financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. Investors should continue to base their decisions on the company's fundamental performance and broader market analysis, as this specific filing is not a material driver for stock price movement.

Keywords

Astera Labs, ALAB, Michael Truett Tate, CFO, Form 4, Insider Transaction, Gift, Common Stock, Beneficial Ownership, Rule 10b5-1